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Madam F. Kayes Bitters® is an herbal formulation commonly used in Nigeria and some African countries in the management of diabetes 
mellitus and other diseases conditions. This study evaluated the in-vivo hypoglycaemic activity, as well as acute toxicity of the polyherbal 
formulation to provide its efficacy and safety. Healthy albino mice (20-30 g) and Sprague Dawley female rats (90-130 g) were used for 
this study. Acute toxicity study (LD50) of the herbal formulation was determined by methods originally described by Miller and Tainter in 
1994. Following oral dosing with glucose (2 g/kg) in normal fasted animals, herbal formulation (HF) at various doses was administered 
and blood glucose levels at 30 minutes, 60 minutes, 90 minutes, and 120 minutes were taken and recorded. Diabetes was induced using 
alloxan 150 mg/kg and diabetic rats were given the HF at doses of 50, 100, and 200 mg/kg with glibenclamide 2.5 mg/kg used as standard 
drug treatment. Blood glucose level was determined on 1st day, 7th day, 14th and 21st day. The LD50 was greater than 5g/kg with oral 
administration. The oral glucose tolerance test showed that the group that received 100 mg/kg HF showed a significant reduction (p<0.05) 
in glucose level after 120 minutes when compared to the basal level of glucose recorded. All treated diabetic groups showed a significant 
decrease in glucose level on the 21st day. The herbal formulation of Hydrastis canadesis Aloe capensis, Echinacea angustifolia and honey 
exhibited a significant glucose-lowering activity in alloxan-induced diabetic rats. 
 





Diabetes mellitus (DM, diabetes) is a chronic disease 
characterized by persistent elevation of blood glucose 
level of an individual which resulting from defects in 
insulin secretion, insulin action, or both (ADA, 2009). 
This disease is also marked by altered lipids, 
carbohydrates and protein metabolism (Ozougwu et al., 
2013; Ezuruike and Prieto, 2014). The hyperglycaemic 
condition takes place due to the inappropriate secretion 
of insulin hormone or the inappropriate use of insulin 
hormone by the body itself. Insulin hormone is secreted 
by the Islet of Langerhans located in the beta cells of 
pancreas and it helps to maintain the glucose level in the 
blood (Xavier, 2018). Besides the storage of glucose, 
insulin also inhibits the secretion of glucagon and lowers 
the concentration of serum fatty acids leading to a 
decline in liver glucose production (Asmat et al., 2016). 
Insufficient insulin or resistance to insulin in the body 
results in reduced tissue uptake of glucose that results in 
intracellular hypoglycemia and extracellular 
hyperglycemia. The intracellular hypoglycemia causes 
glucogenesis and gluconeogenesis that leads to fats 
breakdown (causing diabetic ketoacidosis) and decreases 
protein synthesis and gamma globulins (causing 
cachexia, polyphagia, and impaired wound healing), 
while the extracellular hyperglycemia leads to 
hyperglycemic coma and osmotic dieresis (Ozougwu et 
al., 2013). Based on the requirements of insulin, diabetes 
is classified into insulin-dependent diabetes mellitus 
(Type 1), and non-insulin-dependent diabetes mellitus 
(Type 2) (ADA, 2009). 
Madam F. Kayes Bitters® is an herbal formulation 
commonly used in Nigeria and some African countries 
in the management of diabetes mellitus and other 
diseases conditions. This formulation is listed to be 
composed of Aloe capensis, Hydrastis canadesis, 
Echinacea angustifolia and honey. In spite of significant 
advancements in the development of conventional drugs, 
herbal medicines remain useful in the management of 
diseases, especially in developing countries (Ekor, 2014; 
Erhirhie et al., 2015; Moke et al., 2021). This may be 
due to the adverse effects and high cost of therapy 
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associated with conventional drugs (Gurib-Fakim, 2006; 
Ekor, 2014). 
Medicinal plants are plants whose parts contain 
substances of therapeutic important which can be 
constituted into drug and used for treatment of various 
disease (Sofowora et al., 2013). Many conventional 
drugs such as quinine, aspirin, digoxin, amongst others, 
are of plant origins (Vickers et al., 2001; Veeresham, 
2013). Presently, there is an urgent need to develop safer 
drugs for the management of chronic diseases such as 
diabetes mellitus. Consequently, assessment of various 
medicinal plants used in traditional systems have grown 
(Lahlou, 2013; Sofowora et al., 2013; Ekor, 2014, 
Anachuna et al., 2018; Okafo et al., 2019; Moke et al., 
2020). However, high cost of production is a factor, 
developmental processes for newer drugs is a way of 
evaluating of efficacy and adverse effects of chemical 
substances. The present study aimed to evaluate the in-
vivo hypoglycaemic activity, as well as acute toxicity of 
the polyherbal formula extracts (Madam F. Kayes 
Bitters®) on experimental animals.  
 
 
MATERIAL AND METHODS 
 
Herbal Formulation 
The herbal formulation used was purchased from a local 
pharmacy. It was stored in a cool dry place during the 
period of the study. 
 
Experimental Animals 
Healthy albino mice (20-30 g) and Sprague Dawley 
female rats (90-130 g) were used for this study. These 
were procured from the Animal House of the College of 
Medicine, University of Lagos, Nigeria. The animals 
were kept in polypropylene cages with wire mesh for 
proper ventilation throughout the study. The animals 
were given free access to standard diet (Lifestock Feed 
Plc, Ikeja, Nigeria) and water ad libitum. The animals 
were kept in room temperature with a 12:12 day and 
night cycle and maintained at temperature of 27 ℃. The 
animals were allowed to acclimatize for two weeks 
before commencing the study. The maintenance and 
treatment of the animals was according to the principles 
of the guide for care and use of laboratory animals in 
research and teaching prepared by the National 
Academy of Science and Published by the National 
Institute of Health (NIH) publication 86-23 revised in 
1985.  
 
Acute Toxicity Study 
Acute toxicity study of the herbal formulation was 
determined by methods originally described by Miller 
and Tainter of 1994 (Erhirhie et al., 2018). Mice (20-25 
g) were fasted for 12 hours and divided into four groups 
of 5 mice each. In order to determine the LD50 of the 
formulation, different doses 1000 mg/kg, 2500 mg/kg 
and 5000 mg/kg were administered orally to different 
groups of mice while the control group received 10 
ml/kg distilled water (pH = 6.9). All animals were 
closely observed for symptoms of toxicity and the 
mortality noted. Based on data obtained, the LD50 was 
determined. 
 
Oral Glucose Tolerance Test (OGTT) 
Fifteen adult female rats (100-126 g) were fasted 
overnight. The animals were divided into five different 
groups with three animals each. Blood samples were 
obtained from each rat by gently nipping the tail with a 
lancet, and then gently squeeze the tail to let out 2 drops 
of fresh venous whole blood on the glucometer strip 
inserted and the readings recorded for the 0 minute. 
Different doses of the herbal formulation were orally 
administered. Glucose (2 g/kg) was orally administered 
30 minutes after extract administration to each animal 
according to their body weight. Blood glucose level at 
30 minutes, 60 minutes, 90 minutes, and 120 minutes 
were taken and recorded. 
 
Alloxan-Induced Diabetic Study 
Eighteen healthy female rats were randomly divided into 
6 groups of 3 animals each. The rats were fasted for 24 
hours after which group I rats were given 10 ml/kg 
normal saline while groups II-VI were made 
hyperglycemic with a single intraperitoneal injection of 
150 mg/kg of alloxan monohydrate (Sigma Chemicals 
Company, St. Louis, Mo., U.S.A) (Gbolade et al., 2008; 
Moke et al., 2015). The baseline fasting blood glucose 
was determined prior to the administration of alloxan. 
After 48 hours, blood was collected from the tail vein of 
each rat and the fasting blood glucose level determined. 
A blood glucose ≥ 200 mg/dl was considered diabetic. 
Animals were further tested after 72 hours and animals 
with stable hyperglycemia were selected for the study. 
The treatment schedule of the rats is as follows: 
 Group I (Control) – Normal Saline 10 ml/kg 
 Group II (diabetic and untreated) – Normal Saline 10 
ml/kg 
 Group III – Herbal Formulation 50 mg/kg 
 Group IV – Herbal Formulation 100 mg/kg 
 Group V – Herbal Formulation 200 mg/kg 
 Group VI – Glibenclamide 2.5 mg/kg 
 
Determination of Fasting Blood Glucose in Diabetic 
Rats 
The blood glucose level was determined using the tail 
tipping method after 12-16 hours of fast. The tail was 
gently squeezed to let out 2-3 drops of blood which is 
placed on the test spot of the glucose strip after which 
the test strip was gently inserted into the digital 
glucometer. Blood glucose level was determined on 1st 
day, 7th day, 14th and 21st day.  
 
Data Analysis  
Data were presented as mean ± standard error of mean 
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significance was carried out using a one-way ANOVA. 




RESULTS AND DISCUSSION 
 
Acute Toxicity Test of Herbal Formulation 
When the herbal formulation was administered orally, 
there was no death of experimental animals even at a 
dose of 5g/kg. Hence, for the oral route, the LD50 is 
greater than 5g/kg. (Table 1) 
 







Control 5 Nil 
1000 5 Nil 
2500 5 Nil 
5000 5 Nil 
LD50oral ˃5000mg/kg 
 
Body Weight of Animals 
There was no statistically significant change in body 
weights of the animals (p>0.05) when compared to 
control as shown in Table 2. 
 
 
Table 2. Herbal Formulation treatment on body weights. 
 
Treatment Day 1 (g) Day 7 (g) Day 14 (g) Day 21 (g) 
Control (NS) 103.70±4.91 105.00±5.29 107.3±3.84 115.30±2.60 
Untreated (NS) 106.70±4.49 105.00±3.06 99.67±2.60 97.00±3.22 
GLB 2.5 mg/kg 100.70±6.36 101.00±7.21 99.67±2.60 68.83±28.67 
50 mg HF 107.00±6.56 106.00±5.69 103.70±3.48 105.0±2.52 
100 mg HF 107.00±6.08 104.30±6.94 105.00±3.61 108.00±2.31 
200 mg HF 105.00±5.57 105.70±6.84 105.30±7.42 113.30±16.05 
Values are expressed as mean ± SEM (n=3). p<0.05 statistically significant when day 1 is compared to other respective groups using one way-ANOVA 
followed by Tukey’s post hoc multiple comparison tests.  Key: NS = Normal Saline; GLB = Glibenclamide; HF =Herbal Formulation 
 
 
Oral Glucose Tolerance Test of Herbal Formulation. 
The oral glucose tolerance test showed a sharp decrease 
in the glucose level after 30 minutes when compared to 
the level at 0 minute. This was followed by a gradual 
reduction in glucose level after 60, 90 and 120 minutes. 
The control group showed a statistically significant 
reduction in glucose level at the 90th minute (p<0.01) 
when compared with the basal level recorded 
(78.33±0.88). Glibenclamide showed a significant 
reduction (p<0.01) in glucose level after 120 minutes 
(26±13.01). Also the group that received 100 mg/kg HF 
showed a significant reduction (p<0.05) in glucose level 
after 120 minutes (39.67±2.33) when compared to the 



















Control (NS) 85.33±1.86 104.33±6.57 91.67±5.90 77.33±1.86 87.54±0.88 90.67±2.96 
GLB 2.5 mg/kg 90.33±7.86 106.67±6.77 87.67±12.25 66.00±10.82 43.67±6.64 26.00±13.01** 
50 mg HF 83.33±6.23 104.67±4.41 85.33±9.70 52.67±12.03 67.67±6.94 54.00±13.58 
100 mg HF 87.00±5.86 114.00±10.60 88.33±7.84 60.00±5.29                      61.00±4.58 39.67±2.33* 
200 mg HF 82.67±4.48 116.67±8.84 110.33±8.29 74.33±5.36 71.00±1.53 63.67±6.36 
Values are mean ±SEM (N=3): *p<0.05, **P<0.01 statistically significant compared to basal within group with other respective minutes using one way-




Blood Glucose Level of alloxan-induced Diabetic 
Animals 
The 21 days treatment of alloxan-induced diabetic rats 
with herbal formulation resulted in statistically 
significant reduction in blood glucose (Table 4). There 
was a statistically significant difference between all 
treated groups and the untreated diabetic group when 
compared with the non-diabetic control indicating initial 
hyperglycemic condition upon induction of diabetes. 
On the 7th day, there was a statistical significant 
difference in glucose level in the untreated group 
(p<0.05) and groups administered glibenclamide 
(p<0.01) and 200 mg/kg HF (p<0.001) compared to non-
diabetic control. On the 14th day, there was no 
statistically significant difference in all the treatment 
groups when compared to both diabetic untreated group 
and non-diabetic control group. However, the untreated 
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glucose level when compared with non-diabetic control. 
All treated groups showed a significant decrease in 
glucose level on the 21st day. The p values were as 
follows: glibenclamide (p<0.001), 50 mg/kg HF 



















Control (NS) 53.33±7.31 54.67±7.31 59.33±8.29 48.33±1.20 55.67±5.90 
Untreated (NS) 66.67±11.79 307.70±56.69* 335.30±51.27* 338.30±49.97** 360.00±55.08**** 
GLB 2.5 mg/kg 52.00±1.53 386.70±51.57*** 207.00±67.35** 126.00±62.98 78.67±18.49b 
50 mg HF 78.67±7.75 336.00 ±64.29* 289.30±35.97 116.00±52.81 83.33±13.42b 
100 mg HF 67.00±16.50 383.30±52.03** 260.00±60.65 124.70±11.05 55.00±4.73b 
200 mg HF 72.33±22.72 399.67±25.11** 284.00±44.23** 192.33±39.07 106.70±8.74a 
Values are mean ±SEM (N=3): *p<0.05, **P<0.01, ***P<0.001, ****p<0.0001 versus control; aP<0.001, bP<0.0001 versus untreated control. Analysis 





Over centuries, herbal products of medicinal value 
have been recruited in traditional medicine for the 
management and treatment of several ailments including 
diabetes mellitus (Jung et al., 2006). Although there 
have been a significant advancement in development of 
conventional drugs in recent times, herbal remedies are 
still used especially in developing countries in the 
treatment of diseases (Ekor, 2014; Moke et al., 2021). 
Numerous medicinal plants are widely used in Nigeria 
to manage diabetes mellitus (Abo et al., 2008; Ezuruike 
and Prieto, 2014; Moke et al., 2015; Abubakar et al., 
2017; Okafo et al., 2019). The crude extracts of these 
plants may be used alone or mixed with extracts from 
other plants or other sources. Madam F. Kayes Bitters® 
is a poly-herbal formulation of Aloe capensis, Hydrastis 
canadesis and Echinacea angustifolia plus honey. 
Diabetes mellitus is characterized by persistent 
elevations of fasting blood glucose above 200 mg/dl due 
to insufficient or complete cessation of insulin synthesis 
or secretion and/or peripheral resistance to insulin action 
(Adeneye and Agbaje, 2008; Kitabchi et al., 2009). In 
this study, acute toxicity test revealed that the polyherbal 
formulation is quite safe for oral consumption. The oral 
glucose tolerance test (OGTT) showed a gradual 
reduction in the glucose level from 0 minute to 120 
minutes. This decrease was found to be significant for 
the groups administered the standard treatment 
(glibenclamide) and HF 100mg/kg which suggests that 
the herbal formulation has a glucose lowering effect. 
Following 21 days treatment of alloxan-induced diabetic 
rats with the herbal formulation, there was a significant 
reduction in blood glucose level in all groups receiving 
treatment compared to the untreated diabetic control. 
The reduction in glucose level was gradual in all groups 
with glucose level brought to below 150 mg/dL on the 
14th day with the exception of the group receiving 
200mg/kg. The hypoglycemic effect was more profound 
in the group receiving 100 mg/kg than that of 50 mg/kg 
and 200 mg/kg which suggests that the hypoglycemic 
effect is not dose-dependent.  
The result obtained is consistent with earlier reports 
in scientific literature demonstrating the hypoglycemic 
effect of Aloe barbadensis/Aloe vera (used 
synonymously with Aloe carpensis) in alloxan-induced 
diabetic rats (Nwanjo, 2006; Choudhary et al., 2014; 
Pothuraju et al., 2016; Hammeso et al., 2019). Also 
honey has been shown to exert a dose-dependent 
hypoglycemic effect in diabetic rats (Erejuwa, 2014). 
Honey is sweet and rich in sugars. It is therefore 
surprising that it has a hypoglycemic effect. It has been 
hypothesized that fructose and oligosaccharides present 
in honey may in some way contribute to its observed 
hypoglycemic effect (Erejuwa et al., 2012). Hence, the 
hypoglycemic effect of the herbal formulation 






The polyherbal formulation of Hydrastis canadesis Aloe 
capensis, Echinacea angustifolia and honey exhibited a 
significant glucose-lowering activity in alloxan-induced 
diabetic rats. This suggests that this formulation may be 
useful for the management of diabetes mellitus. This 
study therefore corroborates the claim that this herbal 
formulation is effective in managing diabetes mellitus. 
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